Cognex
Cognex's revenue rose 8.7% to $994 million in fiscal 2025. Its operating margin was 16.4%, up from 12.6% a year earlier. Free cash flow was $237 million, up 76.6%. It paid out $206 million in dividends and buybacks, 87% of free cash flow. The diluted share count fell 1.9%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 2.2% a year and net income 2.5% a year, while buybacks cut the share count by 3%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Cognex yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Cognex's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Cognex's fiscal 2025 free cash flow of $237M, net cash of $337M at December 31, 2025 and 169 million diluted shares, from its filings. The scenarios are fitted to Cognex: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -0.4% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11%: 9% for a business of moderate risk (Electronic Equipment & Instruments), plus 1 point as a smaller company, worth $9.5B, plus 1 point for unsteady results (revenue fell in two of the last five years); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $55.63
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Cognex's earnings per share of $1.04 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 33.3×, the middle of Cognex's own P/E today, its peers' median and its sector's median (the Information Technology median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 12%, 11% and 10%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $55.63
- Value at this multiple, against the last close
- —
- Cognex's P/E at the last close
- 53.5×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| NovantaNOVT | $144.02 | $1.57 | 91.7× |
| CognexCGNX | $55.63 | $1.04 | 53.5× |
| Crane NXTCXT | $56.94 | $2.41 | 23.6× |
| Diebold NixdorfDBD | $68.82 | $3.03 | 22.7× |
| VontierVNT | $34.60 | $2.42 | 14.3× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 324 | 400 | 332 | 246 | 337 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative means net cash) | −324 | −400 | −332 | −246 | −337 |
| Net debt to EBITDA | −1.0x | −1.5x | −2.2x | −1.7x | −1.7x |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | — | — | — | — | — |
| Current ratio | 3.4x | 3.8x | 4.5x | 3.6x | 3.8x |
| Quick ratio | 2.8x | 3.2x | 3.4x | 2.7x | 3.0x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Cognex shares on the open market, and 9 insiders sold $34.8 million, $13.7 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Matthew MoschnerCEO & President, Director | Sold plan | 24,962 | $64.01 | $1.6 million | Form 4 |
| May 27, 2026 | Darren Marc LongVice President | Sold | 20,252 | $66.34 | $1.3 million | Form 4 |
| May 12, 2026 | Laura Ann MacdonaldVP and PAO | Sold | 41,600 | $65.56 | $2.7 million | Form 4 |
| May 11, 2026 | Laura Ann MacdonaldVP and PAO | Sold | 98,122 | $66.80 | $6.6 million | Form 4 |
| May 11, 2026 | Mark FennellChief Legal Officer &Secretary | Sold | 64,873 | $67.05 | $4.3 million | Form 4 |
| Mar 2, 2026 | Dianne M ParrotteDirector | Sold | 44,000 | $54.00 | $2.4 million | Form 4 |
| Feb 23, 2026 | Carl GerstEVP, Global Sales and Products | Sold plan | 10,532 | $55.93 | $589,055 | Form 4 |
| Feb 23, 2026 | Angelos PapadimitriouDirector | Sold | 4,150 | $55.58 | $230,657 | Form 4 |
| Feb 20, 2026 | Joerg KuechenHead of Corporate M&A | Sold | 61,900 | $56.03 | $3.5 million | Form 4 |
| Feb 20, 2026 | Carl GerstEVP, Global Sales and Products | Sold plan | 3,804 | $55.99 | $212,986 | Form 4 |
| Feb 13, 2026 | Robert WillettDirector | Sold plan | 2,148 | $59.50 | $127,806 | Form 4 |
| Feb 12, 2026 | Robert WillettDirector | Sold plan | 177,052 | $58.39 | $10.3 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Fail | Fail |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 5 of 9 | 7 of 9 |
| Accruals ratio | 0.0% | −2.1% | −6.5% |
Compare
Put Cognex side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Cognex | FY25 | 8.7% | 16.4% | 23.8% | 8.4% | −1.7x | 7 | |
| Novanta | FY25 | 3.3% | 9.6% | 4.9% | 6.5% | −0.8x | 5 | Compare |
| Crane NXT | FY25 | 11.4% | 14.9% | 12.0% | 10.4% | 2.6x | 4 | Compare |
| Vontier | FY25 | 3.2% | 18.3% | 14.3% | 15.8% | 2.6x | 6 | Compare |
| Diebold Nixdorf | FY25 | 1.5% | 6.4% | 7.2% | 12.0% | 1.5x | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 530 | 766 | 806 | 726 | 811 | 1,037 | 1,006 | 838 | 914 | 994 |
| Revenue growth | 17.5% | 44.7% | 5.2% | −10.0% | 11.8% | 27.9% | −3.0% | −16.8% | 9.2% | 8.7% |
| Gross profit | 398 | 579 | 600 | 536 | 605 | 760 | 722 | 601 | 626 | 665 |
| Research and development | 78 | 99 | 116 | 119 | 131 | 135 | 141 | 139 | 140 | 139 |
| Operating income | 154 | 259 | 221 | 143 | 170 | 315 | 246 | 131 | 115 | 163 |
| Net income | 144 | 177 | 219 | 204 | 176 | 280 | 216 | 113 | 106 | 114 |
| Diluted EPS (US$) | 0.83 | 0.98 | 1.24 | 1.16 | 1.00 | 1.56 | 1.23 | 0.65 | 0.62 | 0.68 |
| Diluted shares (millions) | 174 | 180 | 177 | 175 | 177 | 180 | 175 | 173 | 173 | 169 |
| Cash flow | ||||||||||
| Cash from operations | 182 | 224 | 224 | 253 | 242 | 314 | 243 | 113 | 149 | 246 |
| Capital expenditure | 13 | 29 | 37 | 22 | 13 | 16 | 20 | 23 | 15 | 9 |
| Free cash flow | 169 | 196 | 186 | 232 | 229 | 299 | 224 | 90 | 134 | 237 |
| Dividends paid | 25 | 29 | 32 | 35 | 390 | 43 | 46 | 49 | 52 | 55 |
| Share buybacks | 47 | 124 | 204 | 62 | 51 | 162 | 204 | 80 | 67 | 151 |
| Acquisitions | 14 | 24 | 4 | 167 | 1 | 0 | 5 | 257 | 1 | 0 |
| Stock-based compensation | 21 | 32 | 41 | 46 | 1 | 44 | 54 | 55 | 52 | 48 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 421 | 404 | 536 | 412 | 372 | 324 | 400 | 332 | 246 | 337 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 1,039 | 1,288 | 1,290 | 1,886 | 1,801 | 2,004 | 1,958 | 2,018 | 1,993 | 2,017 |
| Total liabilities | 76 | 192 | 154 | 530 | 538 | 574 | 520 | 513 | 475 | 525 |
| Shareholders' equity | 963 | 1,096 | 1,135 | 1,356 | 1,262 | 1,430 | 1,438 | 1,505 | 1,518 | 1,492 |
| Margins and ratios | ||||||||||
| Gross margin | 75.2% | 75.5% | 74.5% | 73.8% | 74.5% | 73.3% | 71.8% | 71.8% | 68.4% | 66.9% |
| Operating margin | 29.1% | 33.8% | 27.4% | 19.6% | 21.0% | 30.4% | 24.5% | 15.6% | 12.6% | 16.4% |
| Net margin | 27.1% | 23.1% | 27.2% | 28.1% | 21.7% | 27.0% | 21.4% | 13.5% | 11.6% | 11.5% |
| Free cash flow margin | 32.0% | 25.5% | 23.1% | 31.9% | 28.2% | 28.8% | 22.2% | 10.7% | 14.7% | 23.8% |
| Return on capital | 26.7% | 27.8% | 32.0% | 18.5% | 17.5% | 27.7% | 19.7% | 9.9% | 7.6% | 8.4% |
| Return on equity | 16.0% | 17.2% | 19.7% | 16.4% | 13.5% | 20.8% | 15.0% | 7.7% | 7.0% | 7.6% |
| Return on assets | 14.9% | 15.2% | 17.0% | 12.8% | 9.6% | 14.7% | 10.9% | 5.7% | 5.3% | 5.7% |
| Net debt to EBITDA | −2.5x | −1.5x | −2.2x | −2.5x | −1.9x | −1.0x | −1.5x | −2.2x | −1.7x | −1.7x |